Phase II Study of ME3738 in Chronic Hepatitis C Patients.
Phase 2
- Conditions
- Chronic Hepatitis C
- Registration Number
- JPRN-jRCT2080221187
- Lead Sponsor
- MEIJI SEIKA KAISHA, LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
IFN treatment-naive patients
etc.
Exclusion Criteria
- Patients with chronic liver diseases except chronic hepatitis C, such as chronic hepatitis B, alcoholic hepatitis or autoimmune hepatitis.
- Patients with hepatic cirrhosis or hepatoma
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and Safety
- Secondary Outcome Measures
Name Time Method